Orchestra BioMed Holdings, Inc. director David Pacitti buys $100,000 of stock, first buy in 12 months
The purchase raises the insider's holding by 37%, the filing shows.
A Form 4 filed on Nov 9 shows David Pacitti (Director) purchasing 20,000 Orchestra BioMed Holdings, Inc. shares worth about $100,000 on Nov 9.
The purchase was made in the open market, not through an award, an option exercise or a plan. The trade was reported within two business days, as Section 16 requires.
It is the fifth insider purchase at Orchestra BioMed Holdings, Inc. reported in the last 90 days. With this purchase the insider holds 74,750 shares, 37% more than before.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Orchestra BioMed Holdings, Inc. (OBIO) |
|---|---|
| Insider | David Pacitti |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 20,000 |
| Average price | $5.00 |
| Value | $100,000 |
| Trade date | Nov 9, 2026 |
| Filed with the SEC | Nov 9, 2026, 4:31 PM ET |
| Shares held after | 74,750 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
See all the latest insider trades · See the latest cluster buys and sells
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.